Lista de obras - Ralf Trappe - Dominio Público Uruguay

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.

artículo científico publicado en 2014

A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease?

artículo científico publicado en 2003

Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection.

artículo científico publicado en 2007

BK-VP3 as a new target of cellular immunity in BK virus infection

artículo científico publicado en 2011

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

scientific article published on 15 April 2013

Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an an

artículo científico publicado en 2012

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation

scientific article published on 01 February 2007

Diagnostic and therapeutic management of patients receiving antithrombotic drugs: what to heed?

artículo científico publicado en 2006

Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.

artículo científico publicado en 2013

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

artículo científico publicado en 2005

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

artículo científico publicado en 2008

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course

scientific article published on 04 April 2006

Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients

artículo científico publicado en 2007

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

artículo científico

Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.

scientific article published on 10 February 2014

Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma.

artículo científico publicado en 2012

IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.

artículo científico publicado en 2011

Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein

artículo científico publicado en 2003

Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif

scientific journal article

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

scientific article published on 01 November 2018

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study

artículo científico publicado en 2016

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

artículo científico publicado en 2008

Interindividual variability of response to rituximab: from biological origins to individualized therapies

artículo científico publicado en 2011

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.

artículo científico publicado en 2015

MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution.

artículo científico publicado en 2002

MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin

artículo científico publicado en 2001

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

artículo científico publicado en 2012

Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.

artículo científico publicado en 2013

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

artículo científico publicado en 2014

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and O

article

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

artículo científico publicado en 2006

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab

artículo científico publicado en 2015

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

artículo científico

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution

artículo científico publicado en 2007

Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab

artículo científico publicado en 2007

Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab

artículo científico publicado en 2007

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

artículo científico publicado en 2011

Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification

artículo científico publicado en 2003

Standards and perspectives in locoregional hyperthermia

artículo científico publicado en 2004

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report

artículo científico publicado en 2005

TSPY-LTA transgenic mice develop endocrine tumors of the pituitary and adrenal gland

artículo científico publicado en 2003

Targeted expression of SV40 large tumour antigen (TAg) induces a transient enhancement of spermatocyte proliferation and apoptosis

artículo científico publicado en 2001

The Caenorhabditis elegans ortholog of human PHF5a shows a muscle-specific expression domain and is essential for C. elegans morphogenetic development

artículo científico publicado en 2002

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders

artículo científico publicado en 2012

The expression of human H2A-H2B histone gene pairs is regulated by multiple sequence elements in their joint promoters

scientific article published on 01 September 1999

The human H2A and H2B histone gene complement

artículo científico publicado en 1999

The murine BTB/POZ zinc finger gene Znf131: predominant expression in the developing central nervous system, in adult brain, testis, and thymus

artículo científico publicado en 2002

Therapeutic options in post-transplant lymphoproliferative disorders ⬇️

artículo científico publicado el 1 de diciembre de 2011

Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression.

artículo científico publicado en 2009

Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).

artículo científico publicado en 2009

[Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy]

artículo científico publicado en 2014

[Direct oral anticoagulants (DOAC) in tumor patients]

artículo científico publicado en 2016

Lista de obras de Ralf Trappe

A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.

A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease?

Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection.

BK-VP3 as a new target of cellular immunity in BK virus infection

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an an

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation

Diagnostic and therapeutic management of patients receiving antithrombotic drugs: what to heed?

Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course

Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.

Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma.

IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.

Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein

Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study

Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

Interindividual variability of response to rituximab: from biological origins to individualized therapies

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.

MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution.

MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and O

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution

Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab

Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification

Standards and perspectives in locoregional hyperthermia

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report

TSPY-LTA transgenic mice develop endocrine tumors of the pituitary and adrenal gland

Targeted expression of SV40 large tumour antigen (TAg) induces a transient enhancement of spermatocyte proliferation and apoptosis

The Caenorhabditis elegans ortholog of human PHF5a shows a muscle-specific expression domain and is essential for C. elegans morphogenetic development

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders

The expression of human H2A-H2B histone gene pairs is regulated by multiple sequence elements in their joint promoters

The human H2A and H2B histone gene complement

The murine BTB/POZ zinc finger gene Znf131: predominant expression in the developing central nervous system, in adult brain, testis, and thymus

Therapeutic options in post-transplant lymphoproliferative disorders ⬇️

Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression.

Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).

[Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy]

[Direct oral anticoagulants (DOAC) in tumor patients]